PRECLINICAL PROFILE OF MDL-100907, A POTENT AND SELECTIVE 5-HT2A ANTAGONIST IN DEVELOPMENT FOR SCHIZOPHRENIA

Authors
SORENSEN SM CARR AA VANGIERSBERGEN PLM HITCHCOCK JM KEHNE JH SCHMIDT CJ
Citation
Sm. Sorensen et al., PRECLINICAL PROFILE OF MDL-100907, A POTENT AND SELECTIVE 5-HT2A ANTAGONIST IN DEVELOPMENT FOR SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, pp. 13-13
Citations number
NO
Categorie Soggetti
Psychiatry,Psychiatry,"Clinical Neurology
Journal title
Schizophrenia research → ACNP
ISSN journal
09209964
Volume
18
Issue
2-3
Year of publication
1996
Pages
13 - 13
Database
ISI
SICI code
0920-9964(1996)18:2-3<13:PPOMAP>2.0.ZU;2-#